GLLW
MRNA icon

Graves Light Lenhart Wealth’s Moderna MRNA Stock Holding History

Graves Light Lenhart Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$7K – 414
2022
Q2 		$7K Hold
50
– – ﹤0.01% 515
2022
Q1 		$9K Hold
50
– – ﹤0.01% 550
2021
Q4 		$13K Buy
+50
New +$14.6K ﹤0.01% 576

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Graves Light Lenhart Wealth's MRNA Position: Q3 2022 in Review

Graves Light Lenhart Wealth sold out of Moderna (MRNA) in Q3 2022, closing a stake of 50 shares — an estimated $7K sold.

Graves Light Lenhart Wealth first reported a position in MRNA in Q4 2021 and held it in 3 quarters. The position peaked at $13K in Q4 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Graves Light Lenhart Wealth reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Graves Light Lenhart Wealth sold 50 Moderna shares in Q3 2022, an estimated $7K.
  • Graves Light Lenhart Wealth first reported a position in Moderna in Q4 2021 and held it in 3 quarters.
  • Graves Light Lenhart Wealth's Moderna position peaked at $13K in Q4 2021.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Graves Light Lenhart Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.